120 research outputs found

    Some Questions on No-par-value Stock

    Get PDF

    Capital Stock of No Par Value

    Get PDF

    Relation of Client and Accountant

    Get PDF

    No Par Value Stock

    Get PDF

    Some Phases of the No-par-value-stock Problem

    Get PDF

    Services of Public Accountants to Public Bodies

    Get PDF

    Accountancy in the United States and Canada

    Get PDF

    Master of Science

    Get PDF
    thesisIntrauterine growth restriction (IUGR) increases the risk of chronic lung disease (CLD), and males have worse outcomes. Altered ratios of omega-6 and omega-3 essential fatty acids (EFA) in preterm infants are associated with increased risk of CLD. Conversion of omega-6 and omega-3 EFAs require the same set of EFA conversion enzymes. We hypothesized that IUGR would alter EFA ratios and EFA conversion enzymes in a sex-specific manner in fetal serum, liver and lung. Because maternal docosahexanoic acid (DHA) supplementation has been shown to ameliorate lung dysfunction in IUGR rats, we further hypothesized that alterations in EFA ratios and EFA conversion enzymes would be ameliorated with maternal DHA supplementation. We found that IUGR altered EFA ratios and EFA conversion enzymes in a sex-specific manner. IUGR induced changes in male circulating EFAs that correlate with EFA ratios seen in male preterm infants at increased risk for CLD. Maternal DHA supplementation ameliorated the altered circulating EFAs in male IUGR rats. IUGR induced changes in liver and lung EFA conversion enzyme mRNA and protein did not explain alterations in circulating and lung EFA ratios. We conclude that IUGR induces sex-specific changes in circulating EFA ratios and liver EFA conversion enzymes in newborn IUGR rat pups. We speculate that IUGR induced changes in EFA levels may occur as a result of alterations in placental EFA transfer, and that IUGR impacts placental transfer of EFAs in a sex-specific manner
    corecore